ArticleAmerican journal of hematology2019

Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study.

Noa Biran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.